Ivan A. Lupanov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ivan A. Lupanov has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Pavel S. Dynin
Kirov Military Medical Academy
4 shared publications - Vladimir Yuryevich Lobzin
S.M. Kirov Military Medical Academy
4 shared publications - Igor’ Vyacheslavovich Litvinenko
S.M. Kirov Military Medical Academy
3 shared publications - Andrey Yu. Emelin
Kirov Military Medical Academy, St. Petersburg, Russia
2 shared publications - Daniil A. Solovev
S.M. Kirov Military Medical Academy
2 shared publications - Igor' V. Boykov
Kirov Military Medical Academy
2 shared publications
Latest Publications
- Open Access
- 5 November 2025
- Published by ECO-Vector LLC (Publications) in Russian Military Medical Academy Reports
- Vol. 44 (4) , 395-404
New approaches to spasticity management after spinal cord injury: application of multilevel magnetic stimulation
BACKGROUND: Each year, 5–6 million injuries involving the nervous system are reported worldwide, of which 5%–9% are spinal cord injuries. Although these occur less frequently, the outcomes are severe: up to 100% of affected individuals develop disability or die. Muscle spasticity is one of the most common complications after spinal cord injury, particularly if the cervical and upper thoracic spine is involved. Spasticity develops as a result of damage to descending pathways and loss of inhibitory cortical control. Severe spasticity substantially limits rehabilitation, contributes to contractures and pressure ulcers, reduces quality of life, and increases socioeconomic burden, highlighting the need for more effective treatment methods. AIM: This work aimed to assess the effectiveness of multilevel magnetic stimulation as a method for reducing the severity of muscle spasticity in patients with spastic mono- and paraplegia due to spinal cord injury. METHODS: A comprehensive evaluation was performed in 30 patients with spinal cord injury who were assigned to either the main group or the control group. Spasticity was assessed using the Modified Ashworth Scale. The main group received standard of care combined with multilevel magnetic stimulation, whereas the control group received standard of care alone. RESULTS: Data from 30 patients were analyzed. Four patients in the control group and three in the intervention group were excluded due to absence of spasticity. The mean Modified Ashworth Scale score decreased from 3.73 to 2.00 points in the main group and from 3.58 to 2.08 points in the control group. Although the reduction in both groups was statistically significant, clinical improvement was more pronounced when multilevel magnetic stimulation was used (Cohen’s d: 1.45 vs 0.91, respectively). Intergroup differences did not reach statistical significance, yet the effect size indicates a clear advantage of the experimental technique. The results support the feasibility of multilevel magnetic stimulation as part of comprehensive rehabilitation in spinal cord injury patients. CONCLUSION: Multilevel magnetic stimulation combined with standard therapy provides a more clinically meaningful reduction in spasticity on the Modified Ashworth Scale compared with standard therapy alone. This method represents a promising area in rehabilitation after spinal cord injury and warrants further investigation.
- 5 November 2025
- Published by ECO-Vector LLC (Publications) in Russian Military Medical Academy Reports
- Vol. 44 (4) , 395-404
Open AccessNew approaches to spasticity management after spinal cord injury: application of multilevel magnetic stimulation
BACKGROUND: Each year, 5–6 million injuries involving the nervous system are reported worldwide, of which 5%–9% are spinal cord injuries. Although these occur less frequently, the outcomes are severe: up to 100% of affected individuals develop disability or die. Muscle spasticity is one of the most common complications after spinal cord injury, particularly if the cervical and upper thoracic spine is involved. Spasticity develops as a result of damage to descending pathways and loss of inhibitory cortical control. Severe spasticity substantially limits rehabilitation, contributes to contractures and pressure ulcers, reduces quality of life, and increases socioeconomic burden, highlighting the need for more effective treatment methods. AIM: This work aimed to assess the effectiveness of multilevel magnetic stimulation as a method for reducing the severity of muscle spasticity in patients with spastic mono- and paraplegia due to spinal cord injury. METHODS: A comprehensive evaluation was performed in 30 patients with spinal cord injury who were assigned to either the main group or the control group. Spasticity was assessed using the Modified Ashworth Scale. The main group received standard of care combined with multilevel magnetic stimulation, whereas the control group received standard of care alone. RESULTS: Data from 30 patients were analyzed. Four patients in the control group and three in the intervention group were excluded due to absence of spasticity. The mean Modified Ashworth Scale score decreased from 3.73 to 2.00 points in the main group and from 3.58 to 2.08 points in the control group. Although the reduction in both groups was statistically significant, clinical improvement was more pronounced when multilevel magnetic stimulation was used (Cohen’s d: 1.45 vs 0.91, respectively). Intergroup differences did not reach statistical significance, yet the effect size indicates a clear advantage of the experimental technique. The results support the feasibility of multilevel magnetic stimulation as part of comprehensive rehabilitation in spinal cord injury patients. CONCLUSION: Multilevel magnetic stimulation combined with standard therapy provides a more clinically meaningful reduction in spasticity on the Modified Ashworth Scale compared with standard therapy alone. This method represents a promising area in rehabilitation after spinal cord injury and warrants further investigation.
- Open Access
- 23 October 2025
- Published by Alfmed LLC in Medical alphabet
- No. 21,p. 21-26
Multilevel magnetic stimulation in the treatment of neurogenic pelvic organ dysfunction in patients with spinal cord injury
Each year, 35–40 million cases of spinal cord injury (SCI) are registered worldwide. Among these, 80–100% of patients become disabled or die. In 20% of cases, disability results from neurogenic pelvic organ dysfunction (urination and defecation disorders). This study assessed the effectiveness of multilevel magnetic stimulation (MMS), which combines peripheral, spinal, and transcranial rhythmic magnetic stimulation techniques, in patients with SCI and neurogenic pelvic dysfunction. A total of 30 patients with traumatic SCI were examined. The control group (n=15) received standard therapy, while the experimental group (n=15) additionally underwent MMS. The results showed that MMS was most effective in patients with thoracic spinal cord injuries, demonstrating significant improvements in urinary outflow (p=0.024), bladder filling function (p=0.020), and compensation of urination according to the O. A. Perlmuter’s scale (p=0.038). No statistically significant improvement was observed in the control group. These findings suggest that MMS is a promising method for the rehabilitation of neurogenic pelvic dysfunction in patients with SCI.
- 23 October 2025
- Published by Alfmed LLC in Medical alphabet
- No. 21,p. 21-26
Open AccessMultilevel magnetic stimulation in the treatment of neurogenic pelvic organ dysfunction in patients with spinal cord injury
Each year, 35–40 million cases of spinal cord injury (SCI) are registered worldwide. Among these, 80–100% of patients become disabled or die. In 20% of cases, disability results from neurogenic pelvic organ dysfunction (urination and defecation disorders). This study assessed the effectiveness of multilevel magnetic stimulation (MMS), which combines peripheral, spinal, and transcranial rhythmic magnetic stimulation techniques, in patients with SCI and neurogenic pelvic dysfunction. A total of 30 patients with traumatic SCI were examined. The control group (n=15) received standard therapy, while the experimental group (n=15) additionally underwent MMS. The results showed that MMS was most effective in patients with thoracic spinal cord injuries, demonstrating significant improvements in urinary outflow (p=0.024), bladder filling function (p=0.020), and compensation of urination according to the O. A. Perlmuter’s scale (p=0.038). No statistically significant improvement was observed in the control group. These findings suggest that MMS is a promising method for the rehabilitation of neurogenic pelvic dysfunction in patients with SCI.
- Open Access
- 8 December 2024
- Published by ECO-Vector LLC in Russian Military Medical Academy Reports
- Vol. 43 (4) , 419-427
Early diagnosis of Alzheimer’s disease: potential of 18F-FDG PET as a biomarker of neurodegeneration
BACKGROUND: Dementia is considered one of the most actual medical problems of our time, being one of the main causes of disability among the elderly, and its prevalence will only increase in the coming years. The first place among conditions leading to dementia is given to Alzheimer’s disease (up to 70%). The effectiveness of Alzheimer’s disease therapy largely depends on the timeliness of diagnosis, which leads to the need to search for diagnostic markers that allow to detect the disease at the earliest stages. AIM: To evaluate the possibilities of using 18F-FDG PET for the early diagnosis of Alzheimer’s disease. MATERIALS AND METHODS: Cerebral metabolism was assessed using positron emission tomography with 18F-FDG. A total of 183 patients were divided into groups depending on their diagnosis and the severity of cognitive impairment. RESULTS: A characteristic pattern of cerebral metabolic disorders has been established in patients with Alzheimer’s disease. It can be detected in the early pre-dementia stages and has developmental features as the disease progresses. The pattern was characterized by bilateral hypometabolism in the parietal and temporal cortex with a predominance in its mediobasal sections. An important marker of the development of the neurodegenerative process was a metabolic disorder of the cingulate gyrus, the posterior sections of which are affected already at the earliest stages of the disease, while the involvement of its anterior sections reflects the transition to the stage of severe dementia. Described metabolic disorders prevailed in the dominant (left) brain hemisphere at all stages of the disease. CONCLUSION: Currently 18F-FDG PET can be considered the most informative of the available methods for the early diagnosis of Alzheimer’s disease which have a fairly high degree of accuracy.
- 8 December 2024
- Published by ECO-Vector LLC in Russian Military Medical Academy Reports
- Vol. 43 (4) , 419-427
Open AccessEarly diagnosis of Alzheimer’s disease: potential of 18F-FDG PET as a biomarker of neurodegeneration
BACKGROUND: Dementia is considered one of the most actual medical problems of our time, being one of the main causes of disability among the elderly, and its prevalence will only increase in the coming years. The first place among conditions leading to dementia is given to Alzheimer’s disease (up to 70%). The effectiveness of Alzheimer’s disease therapy largely depends on the timeliness of diagnosis, which leads to the need to search for diagnostic markers that allow to detect the disease at the earliest stages. AIM: To evaluate the possibilities of using 18F-FDG PET for the early diagnosis of Alzheimer’s disease. MATERIALS AND METHODS: Cerebral metabolism was assessed using positron emission tomography with 18F-FDG. A total of 183 patients were divided into groups depending on their diagnosis and the severity of cognitive impairment. RESULTS: A characteristic pattern of cerebral metabolic disorders has been established in patients with Alzheimer’s disease. It can be detected in the early pre-dementia stages and has developmental features as the disease progresses. The pattern was characterized by bilateral hypometabolism in the parietal and temporal cortex with a predominance in its mediobasal sections. An important marker of the development of the neurodegenerative process was a metabolic disorder of the cingulate gyrus, the posterior sections of which are affected already at the earliest stages of the disease, while the involvement of its anterior sections reflects the transition to the stage of severe dementia. Described metabolic disorders prevailed in the dominant (left) brain hemisphere at all stages of the disease. CONCLUSION: Currently 18F-FDG PET can be considered the most informative of the available methods for the early diagnosis of Alzheimer’s disease which have a fairly high degree of accuracy.
- Open Access
- 9 December 2023
- Published by ECO-Vector LLC in Russian Military Medical Academy Reports
- Vol. 42 (4) , 391-402
Comparative assessment of cerebral perfusion and metabolism in patients with Alzheimer’s disease and vascular cognitive disorders
BACKGROUND: The high medical and social significance of the problem determines the necessity of the earliest nosological diagnostics of the cognitive disorders. Functional neuroimaging methods such as single-photon emission computed tomography and positron emission tomography play an important role in the early differential diagnosis, allowing to estimate perfusion and metabolism of the cerebral tissue. AIM: To perform a comparative analysis of perfusion and metabolic abnormalities in different cerebral structures of patients with Alzheimer’s disease and vascular cognitive disorders in small cerebral vessels disease. MATERIALS AND METHODS: Single-photon emission computed tomography was performed in 13 patients with Alzheimer’s disease and in 21 patients with vascular cognitive disorders; positron emission tomography with 18F-FDG was performed in 17 patients with Alzheimer’s disease and in 15 patients with vascular cognitive disorders. RESULTS: Patterns of perfusion and metabolic abnormalities differ in patients with Alzheimer’s disease and vascular cognitive disorders. In patients with vascular cognitive disorders due to cerebral small vessels disease, a distinctive feature was a combination of hypoperfusion in subcortical structures, especially in the caudate nucleus and thalamus, with hypoperfusion in the deep parts of the frontal lobe. In Alzheimer’s disease, bilateral pronounced perfusion abnormalities in the parietal and temporal cortex were the most characteristic. Patterns of metabolic disturbances were similar to patterns of perfusion disturbances in different variants of cognitive disorders, but metabolic disturbances were more widespread. Рositron emission tomography was more informative in diagnosing patients with Alzheimer’s disease compared to single photon emission computed tomography. More pronounced perfusion and metabolic disorders were observed in patients with more severe cognitive disorders. Perfusion disturbances in the area of subcortical structures can be considered as an early marker of cognitive impairment development in patients with small vessel disease. CONCLUSION: Single photon emission computed tomography has sufficient sensitivity and specificity when examining patients with vascular cognitive disorders, while positron emission tomography is more preferable when examining patients with Alzheimer-type dementia.
- 9 December 2023
- Published by ECO-Vector LLC in Russian Military Medical Academy Reports
- Vol. 42 (4) , 391-402
Open AccessComparative assessment of cerebral perfusion and metabolism in patients with Alzheimer’s disease and vascular cognitive disorders
BACKGROUND: The high medical and social significance of the problem determines the necessity of the earliest nosological diagnostics of the cognitive disorders. Functional neuroimaging methods such as single-photon emission computed tomography and positron emission tomography play an important role in the early differential diagnosis, allowing to estimate perfusion and metabolism of the cerebral tissue. AIM: To perform a comparative analysis of perfusion and metabolic abnormalities in different cerebral structures of patients with Alzheimer’s disease and vascular cognitive disorders in small cerebral vessels disease. MATERIALS AND METHODS: Single-photon emission computed tomography was performed in 13 patients with Alzheimer’s disease and in 21 patients with vascular cognitive disorders; positron emission tomography with 18F-FDG was performed in 17 patients with Alzheimer’s disease and in 15 patients with vascular cognitive disorders. RESULTS: Patterns of perfusion and metabolic abnormalities differ in patients with Alzheimer’s disease and vascular cognitive disorders. In patients with vascular cognitive disorders due to cerebral small vessels disease, a distinctive feature was a combination of hypoperfusion in subcortical structures, especially in the caudate nucleus and thalamus, with hypoperfusion in the deep parts of the frontal lobe. In Alzheimer’s disease, bilateral pronounced perfusion abnormalities in the parietal and temporal cortex were the most characteristic. Patterns of metabolic disturbances were similar to patterns of perfusion disturbances in different variants of cognitive disorders, but metabolic disturbances were more widespread. Рositron emission tomography was more informative in diagnosing patients with Alzheimer’s disease compared to single photon emission computed tomography. More pronounced perfusion and metabolic disorders were observed in patients with more severe cognitive disorders. Perfusion disturbances in the area of subcortical structures can be considered as an early marker of cognitive impairment development in patients with small vessel disease. CONCLUSION: Single photon emission computed tomography has sufficient sensitivity and specificity when examining patients with vascular cognitive disorders, while positron emission tomography is more preferable when examining patients with Alzheimer-type dementia.